5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.13▲ | 2.14▲ | 2.11▲ | 2.06▲ | 2.14▼ |
MA10 | 2.13▲ | 2.09▲ | 2.08▲ | 2.11▲ | 2.28▼ |
MA20 | 2.12▲ | 2.07▲ | 2.08▲ | 2.15▼ | 2.28▼ |
MA50 | 2.09▲ | 2.11▲ | 2.13▲ | 2.28▼ | 2.41▼ |
MA100 | 2.12▲ | 2.17▼ | 2.17▼ | 2.32▼ | 4.66▼ |
MA200 | 2.16▼ | 2.23▼ | 2.30▼ | 2.35▼ | 17.47▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.016▲ | 0.014▲ | -0.003▼ | 0.011▲ |
RSI | 54.443▲ | 54.654▲ | 53.848▲ | 48.071▼ | 45.676▼ |
STOCH | 55.354 | 73.876 | 70.637 | 26.694 | 28.446 |
WILL %R | -50.000 | -20.000▲ | -19.048▲ | -66.000 | -72.775 |
CCI | 13.725 | 82.573 | 112.766▲ | -24.877 | -44.587 |
Tuesday, July 01, 2025 05:00 PM
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025. SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer ...
|
Tuesday, July 01, 2025 05:00 PM
SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
|
Tuesday, May 27, 2025 09:35 PM
SUNNYVALE, Calif. - BioCardia (NASDAQ:BCDA), Inc. [Nasdaq: BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 2.13 | 2.192 | 2.0201 | 2.12 | 3,037,617 |
02/07/25 | 2.01 | 2.084 | 2.0001 | 2.084 | 26,555 |
01/07/25 | 1.98 | 2.0722 | 1.95 | 2.00 | 36,349 |
30/06/25 | 2.10 | 2.10 | 1.95 | 1.95 | 78,739 |
27/06/25 | 2.2014 | 2.21 | 2.10 | 2.15 | 26,697 |
26/06/25 | 2.1822 | 2.355 | 2.12 | 2.23 | 101,092 |
25/06/25 | 2.255 | 2.45 | 2.1358 | 2.25 | 174,623 |
24/06/25 | 2.03 | 2.27 | 1.98 | 2.18 | 134,967 |
23/06/25 | 2.10 | 2.1502 | 2.01 | 2.02 | 31,437 |
20/06/25 | 2.17 | 2.17 | 2.075 | 2.08 | 37,812 |
|
|
||||
|
|
||||
|
|